Published in Transplantation on May 27, 2008
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation | NCT00556933
Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days? J Transplant (2010) 0.90
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity. Drugs (2014) 0.84
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
Antibody induction therapy in adult kidney transplantation: A controversy continues. World J Transplant (2012) 0.81
Current state of renal transplant immunosuppression: Present and future. World J Transplant (2012) 0.81
A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition. Transplant Direct (2016) 0.75
A Double-Blind, Double-Dummy, Flexible-Design Randomized Multicenter Trial: Early Safety of Single- Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation. Am J Transplant (2016) 0.75
An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation. Transplant Res (2014) 0.75
Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage. J Nephropathol (2015) 0.75
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med (2005) 4.27
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
The neutropenic diet reviewed: moving toward a safe food handling approach. Oncology (Williston Park) (2012) 2.14
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84
Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis. Blood (2012) 1.60
Successful rehabilitation in pediatric ultrashort small bowel syndrome. J Pediatr (2013) 1.45
Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. Immunol Cell Biol (2011) 1.45
Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl (2006) 1.41
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.39
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. Hepatology (2009) 1.38
Regional manifestations and control of the immune system. FASEB J (2002) 1.38
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2008) 1.36
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2012) 1.35
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 1.23
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis (2005) 1.17
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology (2006) 1.13
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl (2010) 1.11
Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood (2003) 1.10
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation (2005) 1.06
Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One (2009) 1.05
Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care (2011) 1.04
Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system. J Clin Microbiol (2004) 1.02
Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol (2008) 1.00
Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant (2002) 0.99
Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol (2006) 0.98
MOP3, a component of the molecular clock, regulates the development of B cells. Immunology (2006) 0.98
Liver and intestine transplantation. Am J Transplant (2004) 0.97
Antibacterial prophylaxis in patients with neutropenia. J Natl Compr Canc Netw (2007) 0.96
Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion. J Pediatr Gastroenterol Nutr (2013) 0.96
Myeloid growth factors. J Natl Compr Canc Netw (2009) 0.94
Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol (2003) 0.94
Mice with chimeric human livers: who says supermodels have to be tall? Hepatology (2005) 0.92
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clin Infect Dis (2002) 0.92
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol (2005) 0.92
Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant (2011) 0.91
Portosystemic shunts in children: a 15-year experience. J Am Coll Surg (2004) 0.90
Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care (2004) 0.90
Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.90
Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation (2011) 0.90
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.89
Current management of the short bowel syndrome. Surg Clin North Am (2011) 0.89
Current management of short bowel syndrome. Curr Probl Surg (2012) 0.87
Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol (2005) 0.87
Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant (2008) 0.87
Liver transplantation for hepatocellular carcinoma: an update. J Natl Compr Canc Netw (2006) 0.86
Perlecan: a major IL-2-binding proteoglycan in murine spleen. Immunol Cell Biol (2007) 0.86
Short bowel syndrome and Crohn's disease. J Gastrointest Surg (2003) 0.85
No place like home? Outpatient management of patients with febrile neutropenia and low risk. J Clin Oncol (2011) 0.85
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry. Mycoses (2014) 0.85
Stool calprotectin monitoring after small intestine transplantation. Transplantation (2011) 0.83
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int (2007) 0.83
An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation. Transplantation (2014) 0.83
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency. Pediatr Transplant (2013) 0.82
Assessing treatment barriers in young adults with type 1 diabetes. Diabetes Res Clin Pract (2010) 0.82
Altered allogeneic immune responses in middle-aged mice. Cell Mol Immunol (2004) 0.82
Massive small bowel resection during pregnancy causing short bowel syndrome. Am Surg (2011) 0.82
Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg (2002) 0.82
Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients. Res Social Adm Pharm (2012) 0.82
A model of tuberculosis transmission and intervention strategies in an urban residential area. Comput Biol Chem (2010) 0.81
Omeprozole therapy in pediatric patients after liver and intestinal transplantation. J Pediatr Gastroenterol Nutr (2002) 0.81
Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis. Liver Transpl (2012) 0.81
Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant (2003) 0.81
Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes? Clin Transplant (2008) 0.81
Adenovirus infections in pediatric small bowel transplant recipients. Transplantation (2010) 0.80
Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation (2012) 0.80
Bloodstream infections during the first year after pediatric small bowel transplantation. Pediatr Infect Dis J (2012) 0.80
Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis. Expert Rev Anti Infect Ther (2014) 0.80